Pharmacogenomic investigation of adverse drug reactions(ADRs): the ADR prioritization tool, APT.
Shaw K, Amstutz U, Castro-Pastrana L, Loo TT, Ross CJ, Ito S, Reider MJ, Maher M, Macleod S, Koren G, Hayden MR, Carleton BC.
Shaw K, et al. Among authors: amstutz u.
J Popul Ther Clin Pharmacol. 2013;20(2):e110-27. Epub 2013 May 3.
J Popul Ther Clin Pharmacol. 2013.
PMID: 23824325